Log In
Join
GCI
24th February 2020
07:00
AIM - Cancellation - Summit Therapeutics PLC
17th February 2020
17:30
FTSE Russell - Summit Therapeutics
11th February 2020
10:00
AIM Delisting Reminder
10th February 2020
14:15
Director/PDMR Shareholding
6th February 2020
12:00
Summit Therapeutics to Receive $1.0 Million Milestone Payment from Eurofarma
4th February 2020
12:00
Summit Therapeutics to Present at the 2020 BIO CEO & Investor Conference
27th January 2020
07:00
Exercise of Restricted Stock Units
24th January 2020
12:00
Summit Announces Management Update
23rd January 2020
12:00
Summit Announces BARDA Expands Ridinilazole Award by $8.8 Million to Include Additional NDA-Enabling Work
20th January 2020
14:15
Holding(s) in Company
20th January 2020
14:15
Holding(s) in Company
15th January 2020
12:15
Notification of Transactions of Persons Discharging Managerial Responsibilities
7th January 2020
12:00
Summit Therapeutics Launches Online Resource for Patients with C. difficile Infection
31st December 2019
09:00
Holding(s) in Company
30th December 2019
07:00
Holding(s) in Company
24th December 2019
08:30
Completion of $50 million Fundraising and Directorate Change
24th December 2019
07:01
Award of Share Options
24th December 2019
07:00
Exercise of Restricted Stock Units
23rd December 2019
12:00
Result of General Meeting
19th December 2019
07:00
Timetable Update
Load more
Summit Therapeutics Plc (SUMM.L)
Share Price & News
Follow
Unfollow
Price Snapshot
Last Trades
Bid
-
-
-
Ask
High
-
OPEN
-
VOL
-
MKT CAP
-M
LOW
-
CLOSE
-
SHARES IN ISSUE
160.39M
Profile
Financials
RNS
Chart
Media
Board & Advisors
More...
Summit Therapeutics Plc RNS
Watchlist
GCI